With your care providers supervision, you will gradually increase the dose until the most effective, well-tolerated dose is reached
Soc., 59, 8290
The Zepbound (tirzepatide) label recommends switching to a non-oral birth control method, or adding a barrier method, for 4 weeks after starting Zepbound and for 4 weeks after each dose increase
Lengthy authorizations delay treatment
TE is: Common Predictable Temporary Not permanent hair loss In bariatric surgery patients who experience rapid, medically-induced weight loss up to 57% develop telogen effluvium , confirming that this type of shedding is driven by weight-loss physiology, not GLP-1 medications themselves
A., Rasmussen, S., Rossing, P., Wolthers, B., Zinman, B., & Perkovic, V